1123 related articles for article (PubMed ID: 20035032)
1. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
2. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
3. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
4. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
5. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity.
Schrepper A; Schwarzer M; Schöpe M; Amorim PA; Doenst T
J Mol Cell Cardiol; 2012 Jan; 52(1):125-35. PubMed ID: 22100228
[TBL] [Abstract][Full Text] [Related]
6. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
7. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.
Wambolt RB; Henning SL; English DR; Bondy GP; Allard MF
J Mol Cell Cardiol; 1997 Mar; 29(3):939-48. PubMed ID: 9152855
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
9. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
10. Experimental model for heart failure in rats--induction and diagnosis.
Zaha V; Grohmann J; Göbel H; Geibel A; Beyersdorf F; Doenst T
Thorac Cardiovasc Surg; 2003 Aug; 51(4):211-5. PubMed ID: 14502458
[TBL] [Abstract][Full Text] [Related]
11. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure.
Jucker BM; Doe CP; Schnackenberg CG; Olzinski AR; Maniscalco K; Williams C; Hu TC; Lenhard SC; Costell M; Bernard R; Sarov-Blat L; Steplewski K; Willette RN
J Cardiovasc Pharmacol; 2007 Jul; 50(1):25-34. PubMed ID: 17666912
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.
Brower GL; Janicki JS
J Card Fail; 2005 Sep; 11(7):548-56. PubMed ID: 16198252
[TBL] [Abstract][Full Text] [Related]
13. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
14. Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.
Kato T; Niizuma S; Inuzuka Y; Kawashima T; Okuda J; Tamaki Y; Iwanaga Y; Narazaki M; Matsuda T; Soga T; Kita T; Kimura T; Shioi T
Circ Heart Fail; 2010 May; 3(3):420-30. PubMed ID: 20176713
[TBL] [Abstract][Full Text] [Related]
15. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat.
Christe ME; Rodgers RL
J Mol Cell Cardiol; 1994 Oct; 26(10):1371-5. PubMed ID: 7869397
[TBL] [Abstract][Full Text] [Related]
16. Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.
Zhabyeyev P; Gandhi M; Mori J; Basu R; Kassiri Z; Clanachan A; Lopaschuk GD; Oudit GY
Cardiovasc Res; 2013 Mar; 97(4):676-85. PubMed ID: 23257023
[TBL] [Abstract][Full Text] [Related]
17. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
18. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention.
Huggins CE; Domenighetti AA; Ritchie ME; Khalil N; Favaloro JM; Proietto J; Smyth GK; Pepe S; Delbridge LM
J Mol Cell Cardiol; 2008 Feb; 44(2):270-80. PubMed ID: 18191142
[TBL] [Abstract][Full Text] [Related]
19. The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo.
Schwarzer M; Faerber G; Rueckauer T; Blum D; Pytel G; Mohr FW; Doenst T
Basic Res Cardiol; 2009 Sep; 104(5):547-57. PubMed ID: 19294446
[TBL] [Abstract][Full Text] [Related]
20. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
Krayenbühl HP
Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
